全文获取类型
收费全文 | 968篇 |
免费 | 67篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 58篇 |
妇产科学 | 10篇 |
基础医学 | 87篇 |
口腔科学 | 8篇 |
临床医学 | 56篇 |
内科学 | 214篇 |
皮肤病学 | 12篇 |
神经病学 | 57篇 |
特种医学 | 158篇 |
外科学 | 82篇 |
综合类 | 20篇 |
预防医学 | 103篇 |
眼科学 | 3篇 |
药学 | 49篇 |
中国医学 | 4篇 |
肿瘤学 | 119篇 |
出版年
2023年 | 2篇 |
2022年 | 11篇 |
2021年 | 17篇 |
2020年 | 9篇 |
2019年 | 12篇 |
2018年 | 9篇 |
2017年 | 20篇 |
2016年 | 13篇 |
2015年 | 23篇 |
2014年 | 18篇 |
2013年 | 40篇 |
2012年 | 56篇 |
2011年 | 44篇 |
2010年 | 41篇 |
2009年 | 26篇 |
2008年 | 29篇 |
2007年 | 47篇 |
2006年 | 30篇 |
2005年 | 34篇 |
2004年 | 19篇 |
2003年 | 24篇 |
2002年 | 18篇 |
2001年 | 20篇 |
2000年 | 16篇 |
1999年 | 25篇 |
1998年 | 33篇 |
1997年 | 31篇 |
1996年 | 32篇 |
1995年 | 28篇 |
1994年 | 17篇 |
1993年 | 22篇 |
1992年 | 9篇 |
1991年 | 10篇 |
1990年 | 18篇 |
1989年 | 21篇 |
1988年 | 22篇 |
1987年 | 20篇 |
1986年 | 16篇 |
1985年 | 22篇 |
1984年 | 16篇 |
1983年 | 20篇 |
1982年 | 25篇 |
1981年 | 13篇 |
1980年 | 16篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 14篇 |
1976年 | 12篇 |
1975年 | 5篇 |
1974年 | 3篇 |
排序方式: 共有1045条查询结果,搜索用时 31 毫秒
101.
To understand better the relationships between blood-group antigens and bacterial constituents, examples of 23 gram-negative bacteria (representing the 10 genera Citrobacter, Edwardsiella, Enterobacter, Escherichia, Klebsiella, Proteus, Pseudomonas, Salmonella, Serratia, and Shigella) were tested for the presence of Kl-like antigens by hemagglutination-inhibition (HAI) assays against both IgG and IgM anti-Kl. Saline-suspended whole organisms, cell-free culture media, and disrupted organisms were used to test for such antigens in, on, and secreted by the microorganisms examined. Disrupted organisms of an isolate of Shigella sonnei nonspecifically inhibited IgG anti-Kl as well as IgG antibodies of the specificities Kpb, Fya, S, and c. However, only Escherichia coli 0125:B15, subtype 12808, had specific K1-like activity (no activity with other IgG [(k, Kpb, Jka, Fya, S, c] and IgM [A, B, M, P1] antibodies). Disrupted organisms inhibited IgM but not IgG anti-K1 in the HAI assay. A second subtype, E. coli 0125:B15, subtype 12809, exhibited no K1-like activity. These findings support the report of K1 activity in cell-free broth cultures of E. coli 0125:B15 (subtype unspecified). Thus, although not all E. coli 0125:B15 possesses K1-like activity, the finding of such activity in at least one E. coli subtype confirms the idea that bacterial components may play a role in the production of naturally occurring antibodies directed against non-ABO red cell antigens. 相似文献
102.
Although fractures of the clavicle are common, complications are rare. A 41 year old painter developed two uncommon complications of clavicular fracture, mechanical intermittent subclavian artery occlusion and subclavian vein thrombosis. Both conditions were clearly identified on the clinical symptoms and signs and confirmed with dynamic angiography and computerised tomography. Operative intervention led to complete resolution of symptoms. 相似文献
103.
胚胎嗅鞘细胞移植治疗脑性瘫痪:4例术后4周结果报告 总被引:7,自引:3,他引:7
目的:观察胚胎嗅鞘细胞移植治疗脑性瘫痪的有效性和安全性。方法:①病例资料:4例因出生时缺血缺氧确诊为脑性瘫痪的患者,男2例,女2例,年龄分别为14岁、岁、个月、岁。嗅92817鞘细胞由北京市虹天济神经科学研究院细胞中心提供,实验经医学伦理委员会批准,4例脑性瘫痪患者均签署知情同意书。②实验方法:根据术前MRI或CT片,患者均在局麻下行微创立体定向嗅鞘细胞移植术,选取双额放射冠为注射靶点,每侧注射1.0×106个细胞。术后给予止血、抗感染、康复等常规处理。③实验评估:分别于嗅鞘细胞移植前、移植后4周采用脑瘫综合功能评定量表、脑瘫日常生活能力量表评价患者神经功能及生活质量的改善。结果:①嗅鞘细胞移植术后4周,4例患者较术前均有不同程度的神经功能改善,未出现手术并发症。②脑瘫综合功能评定总分:病例1由92.5分增至94分,病例2由55分增至56分,病例3由10.5分增至11.5分,病例4由9.5分增至13分。③脑性瘫痪日常生活能力量表总分:病例1由82.0分增至83.5分,病例2无变化,为16.5分,病例3由5.0分增至7.5分,病例4由5.0分增至8分。结论:嗅鞘细胞移植治疗脑性瘫痪患者近期评价安全可行,可部分改善神经功能与生活质量,长期效果有待进一步随访。 相似文献
104.
Panagiotis Samaras Helen Heider Sarah R. Haile Ulf Petrausch Niklaus G. Schaefer Raffaele Daniele Siciliano Alexander Meisel Axel Mischo Martin Zweifel Alexander Knuth Frank Stenner-Liewen Christoph Renner 《Annals of hematology》2010,89(8):783-787
Preclinical data indicated a detrimental effect of statins on the anti-lymphoma activity of rituximab. We evaluated the impact of concomitant statin medication on the response and survival of patients with diffuse large B cell lymphoma (DLBCL) receiving rituximab–cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP) as first-line therapy. Medical histories of patients with DLBCL who were treated with R-CHOP as first-line therapy were assessed for concomitant statin use, response after completion of chemotherapy, event-free survival (EFS), and overall survival (OS). Furthermore, 2-[18F]fluor-2-deoxyglucose (FDG)-PET/CT results after completion of first-line therapy were compared between the groups. Overall, 145 patients with DLBCL treated with R-CHOP from January 2001 to December 2009 were analyzed. Twenty-one (15%) patients received statins throughout therapy. Five-year EFS was 67.3% in patients without statins compared with 79% in patients receiving statins during R-CHOP (HR, 0.47; 95% CI, 0.15–1.54, p?=?0.2). Five-year OS was 81.4% for patients without statins compared with 93.3% for patients taking statins (HR, 0.58; 95% CI 0.07–4.55, p?=?0.6). There were no statistically significant differences in the rates of complete remissions between the two groups (75% in the non-statin group versus 86% in the statin group, p?=?0.45). A trend toward a lower rate of complete metabolic responses in FDG-PET/CT after chemotherapy was seen in patients without statin medication compared with the patients taking statins (84% versus 92%, p?=?0.068). Concomitant statin use had no adverse impact on response to chemotherapy, EFS, and OS in patients treated with R-CHOP for DLBCL. 相似文献
105.
以单硬脂酸甘油酯和胆固醇为脂质材料,采用乳化溶剂扩散法制备利拉萘酯固体脂质纳米粒,并采用正交设计优化处方.结果表明,所得优化制品平均粒径为(145.3±6.1)nm,包封率为(75.8±0.7)%,载药量为(4.82±0.03)%,DSC分析提示药物可能以无定形状态存在于载体中.稳定性初步研究显示制品在4℃条件放置30 d可维持稳定.体外透皮试验表明,利拉萘酯固体脂质纳米粒凝胶的皮肤滞留比约为市售乳膏(Zefnart)的100倍. 相似文献
106.
Zhang XY Tan YL Zhou DF Cao LY Wu GY Xu Q Shen Y Haile CN Kosten TA Kosten TR 《Journal of psychiatric research》2007,41(12):997-1004
Several lines of evidence suggest that central brain-derived neurotrophic factor (BDNF) modulates food intake, metabolism, and increases in body weight. Reports have also shown that serum BDNF is altered in schizophrenic patients treated with antipsychotics. This study aimed to determine if there was a relationship between BDNF and antipsychotic-induced weight gain in patients with chronic schizophrenia. Serum BDNF was measured in 124 schizophrenia patients chronically treated with clozapine (n = 57), risperidone (n = 23) or typical antipsychotics (n = 44) and 50 healthy control subjects. To further assess group differences in serum BDNF, additional analyses were performed in a subset of patients and controls individually matched for body mass index (BMI). BDNF levels were lower in patients with schizophrenia than normal controls. However, this difference was not present when controlling for current BMI. In the individually BMI-matched sample, no differences in serum BDNF levels were observed in schizophrenic patients compared to BMI-matched healthy controls. BDNF levels negatively correlated with BMI gain in female but not in male patients when gender was considered. Antipsychotic class exerted differential effects over BDNF levels and BMI gain. Our findings suggest that decreased BDNF levels may be associated with weight gain in female schizophrenic patients on long-term antipsychotic treatment. 相似文献
107.
108.
The aim of the study was to examine the order of testing sequence on a child's ability to achieve maximal anaerobic and aerobic power. Thirty-two children (20 females, 12 males) between 7 - 11 years of age participated in this study. All subjects were tested on three separate occasions as follows: anaerobic power session - Wingate Anaerobic Test (WAnT) only; aerobic power session - maximal oxygen consumption (V.O (2max)) test only; and experimental session - WAnT followed by a V.O (2max) test (WAnT/V.O (2max)) or a V.O (2max) test followed by a WAnT (V.O (2max)/WAnT), each with 20 minutes of rest between the assessments. No significant differences were observed between the baseline WAnT or V.O (2max) between the two groups. No significant differences were observed for WAnT power values in either group regardless of testing sequence. Children in the WAnT/V.O (2max) group had significantly lower experimental V.O (2max) (38.6 +/- 7.6 vs. 40.6 +/- 7.4 mL . kg (-1) . min (-1); p < 0.05), RER (1.10 +/- 0.08 vs. 1.13 +/- 0.07; p < 0.05), and exercise time (472 +/- 87 vs. 511 +/- 79 s; p < 0.01) values when compared to the baseline V.O (2max) test. The results of this study indicate that when assessing a child's anaerobic and aerobic power during the same testing session, the testing sequence is of importance. However, it appears that a V.O (2max) test can be performed 20 minutes prior to the WAnT without affecting anaerobic power in children. 相似文献
109.
Levine AJ Lee W Figueiredo JC Conti DV Vandenberg DJ Davis BD Edlund CK Henning SM Heber D Stern MC Haile RW 《Cancer causes & control : CCC》2011,22(4):541-552